
Gome Bio develops therapies and tools to treat life-threatening diseases. It leverages immunoengineering, genome writing, AI-driven vaccine design, and quantum vaccinomics to advance a biotech platform that supports immune-instructive materials, gene designs, diagnostics, and next-generation vaccines. Core technology spans computational biology, machine learning, and structural biology, enabling genome-level design and immune modulation. The company positions itself as a B2B biotech player collaborating with pharmaceutical and research partners to scale therapies for respiratory cancers, infections, neurological conditions, and other serious diseases. Located in the Tri-Valley region of California.

Gome Bio develops therapies and tools to treat life-threatening diseases. It leverages immunoengineering, genome writing, AI-driven vaccine design, and quantum vaccinomics to advance a biotech platform that supports immune-instructive materials, gene designs, diagnostics, and next-generation vaccines. Core technology spans computational biology, machine learning, and structural biology, enabling genome-level design and immune modulation. The company positions itself as a B2B biotech player collaborating with pharmaceutical and research partners to scale therapies for respiratory cancers, infections, neurological conditions, and other serious diseases. Located in the Tri-Valley region of California.